(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer

Monoclonal antibodies (mAbs) against the epidermal growth factor receptor (EGFR) are used in the treatment of advanced colorectal cancer (mCRC). Approximately 50% of patients benefit despite patient selection for RAS wild type (wt) tumors. Based on the hypothesis that tumor targeting is required for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Menke-van der Houven van Oordt, Catharina Willemien, Gootjes, Elske C., Huisman, Marc C., Vugts, Danielle J., Roth, Chantal, Luik, Anne Marije, Mulder, Emma R., Schuit, Robert C., Boellaard, Ronald, Hoekstra, Otto S., van Dongen, Guus AMS, Verheul, Henk M.W.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745807/
https://ncbi.nlm.nih.gov/pubmed/26309164
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados